Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioCentury

12:39 EDT 19th June 2018 | BioPortfolio

Here are the most relevant search results for "BioCentury" found in our extensive news archives from over 250 global news sources.

More Information about BioCentury on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioCentury for you to read. Along with our medical data and news we also list BioCentury Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioCentury Companies for you to search.

Showing News Articles 1–25 of 4,100+ from BioCentury

Tuesday 19th June 2018

Emulate raises $36M series C to improve Organ-Chips offering

Monday 18th June 2018

BridgeBio launches mitochondrial-focused subsidiary

Hold for upcoming point-of-care CAR T trial sinks Ziopharm shares

Payers, drugmakers face off over CAR T Medicare coverage

Researchers identify new class of antimicrobials

Antibodies neutralize Catalyst's Factor IX variant, crater stock

PTC spikes on interim pivotal data for oral SMA candidate

Qiming leads series B for cancer play WindMIL

Vertex gets reimbursement deal for Orkambi in Sweden

Stealth to start Phase IIb of AMD candidate with $100M financing

Management tracks: Ionis, Albireo

Valeant slides on psoriasis delay

Medivir delays remetinostat Phase III

FDA lifts clinical hold on Solid's DMD gene therapy

Allogene names Schmidt CFO

Friday 15th June 2018

MATCH’s long game

NCI-MATCH has produced responses in rare cancers and mechanistic insights that will guide future studies.

No easy way up

Searching for solutions at Allergan as activist investors beginning to circle.

NSCLC disrupted

The swift rise of immunotherapy to first-line NSCLC means companies need to rethink their drug development programs in the indication.

Rejuvenating aging

Anti-aging company Juvenescence hopes to bring 10 candidates into clinic in two years and go public next year.

NIH pulls funding from compromised alcohol/CV health trial

bluebird on track to submit MAA to EMA for LentiGlobin

Massachusetts reauthorizes life science initiative

ThinkCyte launches with AI-based high-throughput cell sorter

Healthcare products dropped from tariffs against China

House committee to consider NIH raise


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks